A number of respiratory conditions largely affect the paediatric patient, including cystic fibrosis, asthma and allergy. Recent research into genetic drivers has revolutionized the treatment of cystic fibrosis, with new and effective targeted therapies available and undergoing further research. In asthma, treatments such as inhaled corticosteroids are well established, but research into innovative therapies is ongoing.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Leading experts in Pompe disease explore key data from WMS 2024 and WORLDSymposium 2025.
We are excited to welcome you to San Francisco for the ATS 2025 International Conference! Leaders, as well as emerging scientists and clinicians, who are at the forefront of medical breakthroughs and clinical innovation in pulmonary, critical care and sleep medicine will gather for networking and inspiring talks.
The International Primary Care Respiratory Group (IPCRG), is proud to host the 8th IPCRG Scientific Meeting in Brașov, Romania, on Friday 11 and Saturday 12 April 2025. This event, in partnership with the RespiRO team and the Transilvania University of Brașov promises to bring together researchers, innovators, and industry leaders to advance respiratory care in primary health settings.
Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
Dupilumab is indicated as an add-on maintenance treatment in children aged 6 years and older with asthma, and demonstrated clinical efficacy in the pivotal VOYAGE study (NCT0294895). We caught up with Dr Theresa W Guilbert (Cincinnati Children's Hospital & Medical Center; ...
touchRESPIRATORY were delighted to speak with Dr Theresa W Guilbert (Cincinnati Children's Hospital & Medical Center; University of Cincinnati, Cincinnati, OH, USA) about the health and economic burden of asthma exacerbations in children, and the limitations of current therapeutic options ...
The InPedILD trial was a phase 3, double-blind placebo-controlled trial investigating nintedanib in children and adolescents with fibrosing interstitial lung diseases (ClinicalTrials.gov: NCT04093024). We were delighted to speak to Dr. Robin Deterding (University of Colorado; Children's Hospital Colorado, Aurora, CO, ...
Nintedanib is an inhibitor of tyrosine kinases involved in the progression of pulmonary fibrosis and blocks the signalling pathways involved in fibrotic processes. We were delighted to speak to Dr. Robin Deterding (University of Colorado; Children's Hospital Colorado, Aurora, CO, ...
Dr Julie Parsons reviews the diagnosis and approved treatments for later-onset SMA, highlighting their impact on the natural history of SMA.
Watch members of the MDT and two patients discuss the diagnosis and management of SMA in adolescents and adults.
Respiratory syncytial virus (RSV) is a ubiquitous virus that causes annual epidemics of infection in young children in all parts of the world. In temperate regions, epidemics are seasonal, and predictable during the winter months. Approximately half of all infants ...
Editorial board member and new Chair Elect of the Paediatric Respiratory Physiology and Sleep Section of the ERS Paediatric Assembly Refika Ersu (Marmara University, Istanbul, Turkey) chats to us about unmet needs and exciting advances in respiratory and sleep physiology ...
Editorial board member Fabio Midulla (Sapienza University, Rome, Italy) chats to us about acute viral bronchiolitis, including risk factors, challenges managing the condition, risks and recent advances. Questions 1. What are the major risk factors for acute viral bronchiolitis? (0:12) 2. What are ...
My experience in the care of ventilator-dependent children involves over 20 years’ experience in both the home and long-term care environments. I have managed over 50 ventilator-dependent children in a university-based practice and have weaned at least two children per year ...
Inducible laryngeal obstruction (ILO), previously designated as vocal cord dysfunction (VCD), is characterised by a transient and reversible narrowing of the larynx in response to external triggers, resulting in symptoms such as cough, dyspnoea and noisy breathing.1,2 Adduction of the ...
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.